Search results

Selected filters:

Finance
Analysis

Article type

Topic

Sector

Regions

Year

421 results found for your search

Sort options
11 July 2019

China’s venture community knows patents don’t equal innovation

The CEO of a hot AI startup, a top China-focused VC and Lenovo’s CIO shared their views on patents, innovation and trade tensions at one of Asia’s largest tech events

28 June 2019

Politics, money could temper Chinese interest in Intel auction

A few years ago, it might have been different. But political, legal and economic uncertainty may combine to keep firms like Huawei and ZTE out of the running for Intel’s wireless IP

30 May 2019

$1 billion Keytruda deal illustrates value of royalty right sales for research institutes

Transformative agreement shows why niche investment model may appeal to cash-strapped life sciences innovators

27 May 2019

New IP Bridge co-CEO talks licensing in China, Avanci’s prospects in Japan and company's 'next phase'

Minoru Fujiki (pictured, right) has taken charge of the fund operator’s patent business after the departure of founding CEO Shigeharu Yoshii (centre)

17 May 2019

The pledge that may reduce Tesla’s value as it seeks additional funds

In 2014, Elon Musk vowed not to sue anyone for patent infringement if they used the company’s technology in “good faith”. Five years later and that may not look to be such a great idea

07 May 2019

Faraday Future seeks lifeline from $1.25 billion IP valuation

Cash-strapped electric vehicle start-up hopes to attract much-needed funding after Houlihan Lokey estimate of the value of its portfolio, which includes tech, patents and trademarks 

30 April 2019

Subsidy cuts will spark tech and patent competition in China's crowded EV market

Beijing is slashing handouts for electric vehicle purchases, setting up a reckoning for domestic competitors in a crowded market. Technology will be crucial to survival, and IP strategy will be more important than ever

05 April 2019

Future of former Yahoo! patents comes back on the agenda 

No free passes insists Excalibur head as he contemplates future of $250m portfolio after parent company announces dissolution

14 March 2019

New research highlights impact of patent eligibility uncertainty on life sciences and tech investments

Academic calls for Congress to act on 101 “to restore investor confidence” with private equity and VC players clear that doubts over patentability make it less likely they will part with cash

08 March 2019

IP Bridge approaches milestone transition to private backing

The public-private INCJ is getting ready to exit in the IP business run by Shigeharu Yoshii (pictured, centre). The patent fund operator’s second act will tell us much about Japan’s IP market

21 February 2019

Burford takes aim at opioid overdose medication in series of IPRs

Reviews challenge validity of patents owned by Opiant Pharmaceuticals relating to Narcan brand of naloxone as price of treatments rises

19 February 2019

New Acacia chief IP officer charts a different course for the once mighty NPE

Supported by a healthy balance sheet, Marc Booth says the firm plans on a higher volume of smaller deals with three new areas identified for future growth

15 February 2019

Takeover wars intensify between listed IP firms in Australia

Aggressive move by the country’s largest public IP services group seems designed to thwart the merger of two smaller rivals. But further consolidation in the space still looks likely

12 February 2019

New investment platform aims to break down barriers to capital for innovators

Former IV unit teams up with alternative asset business to give large and small innovators way of attracting finance on Blockchain-based initiative

28 January 2019

Critical condition: has Section 101 put the US medical device sector on life support?

As fears grow over subject-matter eligibility and technological convergence threatens to reshape the competitive landscape, patent strategy has become even more crucial for medical device companies